Tag: CX 2024
Access monitoring and vessel management spotlighted in Renal Interventions Controversies session
During the Renal Interventions Controversies programme that took place on the first day of the recent Charing Cross (CX) International Symposium (23–25 April, London,...
Renal Interventions’ top 10 stories of April 2024
April was a month of world-firsts, new collaborations, and useful data, with a team from Massachusetts General Hospital (Boston, USA) performing the world’s first...
“We know which DCB to use”—but many other questions remain in...
A first-time presentation of five-year data from the IN.PACT AV Access study evaluating the IN.PACT AV (Medtronic) drug-coated balloon (DCB) today led principal investigator...
CX 2024 promises “not only the complex, the new, the innovative,...
CX Executive Board members Nicholas Inston (Birmingham, United Kingdom) and Kate Steiner (Stevenage, United Kingdom) discuss some of the highlights of this year’s CX...
Renal Interventions 11 – EU
Highlights
New trial evidence about the benefits of preoperative forearm exercises for vein diameter from Koen van der Bogt (Leiden, The Netherlands)
The importance...
Renal Interventions 11 – US
Highlights
New trial evidence about the benefits of preoperative forearm exercises for vein diameter from Koen van der Bogt (Leiden, The Netherlands)
The importance...